186 related articles for article (PubMed ID: 32623380)
1. Menstrual cycle, reproductive function, body mass index, and metabolic profiles of women with former central precocious puberty: 10-20-year longitudinal cohort study in southern Thailand.
Satitpatanapan P; Jaruratanasirikul S; Sriplung H
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):933-940. PubMed ID: 32623380
[TBL] [Abstract][Full Text] [Related]
2. Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades.
Lazar L; Lebenthal Y; Yackobovitch-Gavan M; Shalitin S; de Vries L; Phillip M; Meyerovitch J
J Clin Endocrinol Metab; 2015 Apr; 100(4):1445-51. PubMed ID: 25650898
[TBL] [Abstract][Full Text] [Related]
3. One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty.
Arcari AJ; Freire AV; Escobar ME; Ballerini MG; Ropelato MG; Bergadá I; Gryngarten MG
J Pediatr Endocrinol Metab; 2019 Feb; 32(2):181-186. PubMed ID: 30699070
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal 15-year follow-up of women with former early puberty: abnormal metabolic profiles not associated with earlier age at onset of puberty, but associated with obesity.
Jaruratanasirikul S; Satitpatanapan P; Sriplung H
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):71-77. PubMed ID: 33180041
[TBL] [Abstract][Full Text] [Related]
5. GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome.
Chiavaroli V; Liberati M; D'Antonio F; Masuccio F; Capanna R; Verrotti A; Chiarelli F; Mohn A
Eur J Endocrinol; 2010 Jul; 163(1):55-62. PubMed ID: 20356934
[TBL] [Abstract][Full Text] [Related]
6. Body mass index evolution and ovarian function in adolescent girls who received GnRH agonist treatment for central precocious puberty or early and fast puberty.
Buyukyilmaz G; Koca SB; Adiguzel KT; Gurbuz F; Boyraz M
J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1044-1051. PubMed ID: 37735929
[TBL] [Abstract][Full Text] [Related]
7. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function.
Heger S; Müller M; Ranke M; Schwarz HP; Waldhauser F; Partsch CJ; Sippell WG
Mol Cell Endocrinol; 2006 Jul; 254-255():217-20. PubMed ID: 16757104
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Polycystic Ovarian Syndrome in Girls with a History of Idiopathic Central Precocious Puberty.
Arcari AJ; Freire AV; Ballerini MG; Escobar ME; Díaz Marsiglia YM; Bergadá I; Ropelato MG; Gryngarten MG
Horm Res Paediatr; 2024; 97(2):134-139. PubMed ID: 37552972
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
10. The effect of gonadoliberin analog treatment in precocious puberty on polycystic ovarian syndrome prevalence in adulthood.
Orszulak D; Niziński K; Bil A; Gawlik A; Ziora K; Drosdzol-Cop A
Front Endocrinol (Lausanne); 2024; 15():1314752. PubMed ID: 38327564
[TBL] [Abstract][Full Text] [Related]
11. Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression.
Sørensen K; Mouritsen A; Mogensen SS; Aksglaede L; Juul A
J Clin Endocrinol Metab; 2010 Aug; 95(8):3736-44. PubMed ID: 20484471
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.
Magiakou MA; Manousaki D; Papadaki M; Hadjidakis D; Levidou G; Vakaki M; Papaefstathiou A; Lalioti N; Kanaka-Gantenbein C; Piaditis G; Chrousos GP; Dacou-Voutetakis C
J Clin Endocrinol Metab; 2010 Jan; 95(1):109-17. PubMed ID: 19897682
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
14. Outcomes of Patients with Central Precocious Puberty Due to Loss-of-Function Mutations in the MKRN3 Gene after Treatment with Gonadotropin-Releasing Hormone Analog.
Ramos CO; Macedo DB; Canton APM; Cunha-Silva M; Antonini SRR; Stecchini MF; Seraphim CE; Rodrigues T; Mendonca BB; Latronico AC; Brito VN
Neuroendocrinology; 2020; 110(7-8):705-713. PubMed ID: 31671431
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Patients with Central Precocious Puberty due to Hypothalamic Hamartoma after GnRHa Treatment: Anthropometric, Metabolic, and Reproductive Aspects.
Ramos CO; Latronico AC; Cukier P; Macedo DB; Bessa DS; Cunha-Silva M; Arnhold IJ; Mendonca BB; Brito VN
Neuroendocrinology; 2018; 106(3):203-210. PubMed ID: 28558376
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
17. Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty.
Thornton P; Silverman LA; Geffner ME; Neely EK; Gould E; Danoff TM
Pediatr Endocrinol Rev; 2014 Mar; 11(3):306-17. PubMed ID: 24719967
[TBL] [Abstract][Full Text] [Related]
18. MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty.
Guaraldi F; Beccuti G; Gori D; Ghizzoni L
Eur J Endocrinol; 2016 Mar; 174(3):R79-87. PubMed ID: 26466612
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty.
Kim EY
Korean J Pediatr; 2015 Jan; 58(1):1-7. PubMed ID: 25729392
[TBL] [Abstract][Full Text] [Related]
20. Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades.
Lazar L; Meyerovitch J; de Vries L; Phillip M; Lebenthal Y
Clin Endocrinol (Oxf); 2014 Apr; 80(4):570-6. PubMed ID: 24033561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
